Pharma Mar (MEX:PHM1N) Cyclically Adjusted Book per Share: MXN0.00 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MEX:PHM1N Pharma Mar SA MEX:PHM1N
68 GF Score
Price MXN1,608.38
GF Value MXN1,734.34
! 2 Warning Signs
View Full Analysis

What is Pharma Mar Cyclically Adjusted Book per Share?

Pharma Mar MEX:PHM1N 68 Cyclically Adjusted Book per Share is MXN0.00 as of Jun. 2026. GuruFocus rates MEX:PHM1N with a GF Score™ of 68/100 and a GF Value™ of MXN1,734.34. The stock has 2 warning signs investors should review.

Note: As Cyclically Adjusted Book per Share is a main component used to calculate Cyclically Adjusted PB Ratio. If the month end stock price for this stock is zero, result may not be accurate due to the exchange rate between different shares and the data will not be stored into our database. Selected historical data showed in the calculation section below is only for demostration purpose.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Pharma Mar's adjusted book value per share for the three months ended in Jun. 2026 was MXN291.299. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is MXN0.00 for the trailing ten years ended in Jun. 2026.

During the past 12 months, Pharma Mar's average Cyclically Adjusted Book Growth Rate was 15.80% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was 15.90% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was 21.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Pharma Mar was 26.10% per year. The lowest was -12.10% per year. And the median was 15.90% per year.

As of today (2026-08-10), Pharma Mar's current stock price is MXN1608.38. Pharma Mar's Cyclically Adjusted Book per Share for the quarter that ended in Jun. 2026 was MXN0.00. Pharma Mar's Cyclically Adjusted PB Ratio of today is .

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Pharma Mar was 49.07. The lowest was 3.90. And the median was 11.05.


Pharma Mar  (MEX:PHM1N) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Pharma Mar was 49.07. The lowest was 3.90. And the median was 11.05.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Pharma Mar Cyclically Adjusted Book per Share Related Terms


Pharma Mar Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Pharma Mar's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pharma Mar Cyclically Adjusted Book per Share Chart

Pharma Mar Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 103.24 119.32 223.95 131.41 159.33

Pharma Mar Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 141.21 125.97 159.33 142.44 0.00

MEX:PHM1N vs VRTX, REGN, RVMD: Cyclically Adjusted Book per Share Comparison

For the Biotechnology subindustry, Pharma Mar's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pharma Mar Cyclically Adjusted PB Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Pharma Mar's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Pharma Mar's Cyclically Adjusted PB Ratio falls into.


MEX:PHM1N
68GF Score
Pharma Mar SA MEX:PHM1N
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Pharma Mar Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Pharma Mar's adjusted Book Value per Share data for the three months ended in Jun. 2026 was:

Adj_Book= Book Value per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=291.299/131.3300*131.3300
=291.299

Current CPI (Jun. 2026) = 131.3300.

Pharma Mar Quarterly Data

Book Value per Share CPI Adj_Book
201609 70.665 99.737 93.050
201612 61.831 101.842 79.734
201703 54.636 100.896 71.116
201706 51.953 101.848 66.992
201709 45.976 101.524 59.474
201712 33.862 102.975 43.186
201803 31.031 102.122 39.906
201806 37.379 104.165 47.127
201809 38.050 103.818 48.133
201812 25.897 104.193 32.642
201903 13.536 103.488 17.178
201906 0.152 104.612 0.191
201909 -6.242 103.905 -7.890
201912 12.886 105.015 16.115
202003 113.959 103.469 144.645
202006 151.993 104.254 191.467
202009 140.662 103.521 178.449
202012 137.240 104.456 172.549
202103 170.960 104.857 214.121
202106 178.204 107.102 218.516
202109 192.339 107.669 234.607
202112 228.976 111.298 270.189
202203 245.693 115.153 280.209
202206 243.245 118.044 270.622
202209 233.720 117.221 261.851
202212 254.287 117.650 283.854
202303 232.945 118.948 257.194
202306 217.287 120.278 237.252
202309 215.432 121.343 233.164
202312 202.985 121.300 219.770
202403 198.522 122.762 212.377
202406 203.938 124.409 215.284
202409 229.130 123.121 244.408
202412 258.904 124.753 272.553
202503 249.513 125.531 261.040
202506 251.077 127.251 259.126
202509 247.598 126.840 256.363
202512 305.855 128.400 312.834
202603 300.757 129.860 304.162
202606 291.299 131.330 291.299

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of MXN0.00 mean?
Pharma Mar (MEX:PHM1N) has a Cyclically Adjusted Book per Share of MXN0.00 as of Jun. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Pharma Mar and its competitors.
Is Pharma Mar's Cyclically Adjusted Book per Share too high?
Pharma Mar's current Cyclically Adjusted Book per Share is MXN0.00. Overall, Pharma Mar has a GF Score™ of 68/100, reflecting its overall financial health beyond just this single metric.
How does Pharma Mar's Cyclically Adjusted Book per Share compare to VRTX and REGN?
Pharma Mar's Cyclically Adjusted Book per Share of MXN0.00 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Biotechnology company?
A good Cyclically Adjusted Book per Share depends on the Biotechnology industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Pharma Mar and its competitors. Pharma Mar's current Cyclically Adjusted Book per Share is MXN0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pharma Mar stock overvalued right now?
Pharma Mar (MEX:PHM1N) has a current Cyclically Adjusted Book per Share of MXN0.00. The stock's GF Value™ is MXN1,734.34, compared to a current price of MXN1,608.38 — trading 7.3% below its estimated fair value. The current Cyclically Adjusted Book per Share is MXN0.00. Pharma Mar's overall GF Score™ is 68/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Pharma Mar (MEX:PHM1N), the current Cyclically Adjusted Book per Share is MXN0.00 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Pharma Mar (MEX:PHM1N) Overvalued in 2026?

Based on GuruFocus' analysis, Pharma Mar stock appears to be undervalued. The current stock price of MXN1,608.38 is trading 7.3% below its estimated GF Value™ of MXN1,734.34.

Key valuation signals for MEX:PHM1N:

  • Cyclically Adjusted Book per Share: MXN0.00
  • GF Value™: MXN1,734.34 vs. price of MXN1,608.38 (7.3% below fair value)
  • GF Score™: 68/100 with 2 warning signs

No single metric tells the full story. See the MEX:PHM1N stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Pharma Mar Business Description

Address Avenida de los Reyes, 1, Poligono Industrial La Mina-norte, Colmenar Viejo, Madrid, ESP, 28770
Pharma Mar SA is engaged in the research, development, production, and commercialization of bio-active principles of marine origin for application in oncology. It also produces and markets insecticides and air fresheners for household use, household products, wood treatment and decoration products, paints, and similar products. Its operating business segments are Oncology and RNAi. The company obtains its revenues from two main areas: biopharmaceuticals and consumer chemicals, but the biopharmaceuticals is the main line of business.
68GF Score

Get the complete analysis for MEX:PHM1N

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN1,608.38
Price
MXN1,734.34
GF Value